BNP Paribas Financial Markets
RCPI

BNP Paribas Financial Markets’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

BNP Paribas Financial Markets’s Portfolio RCPI Stock Details RCPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-638
Closed -$4.47K – 4038
2014
Q3 		$4.47K Buy
+638
New +$6.3K ﹤0.01% 3836

Other funds holding RCPI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
GCM
Goldman Capital Management New York $103M AUM 21.37% 1-Year Est. Return
TC
Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BNP Paribas Financial Markets's RCPI Position: Q4 2014 in Review

BNP Paribas Financial Markets sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q4 2014, closing a stake of 638 shares — an estimated $4.47K sold.

BNP Paribas Financial Markets first reported a position in RCPI in Q3 2014 and held it in 1 quarter. The position peaked at $4.47K in Q3 2014. 55 funds tracked by Wall St. Rank hold RCPI as of Q4 2014.

  • BNP Paribas Financial Markets reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 638 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q4 2014, an estimated $4.47K.
  • BNP Paribas Financial Markets first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q3 2014 and held it in 1 quarter.
  • BNP Paribas Financial Markets's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $4.47K in Q3 2014.
  • 55 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q4 2014.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2014, filed 11 Feb 2015.